Laura-alejandra Tirado-Ramirez
Av. San Fernando No. 22, CP 14080
Tlalpan, DIF 14080, Mexico
Tlalpan, DIF 14080, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status.
Journal: Thoracic cancer
Published: January 03, 2020
Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer.
Journal: Cancer medicine
Published: April 22, 2019
Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an EGFR mutation.
Journal: Journal of thoracic disease
Published: June 01, 2018
Response Assessment of 68Ga-DOTA-E-[c(RGDfK)]2 PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus Docetaxel.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 28, 2017
Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancer.
Journal: Oncology letters
Published: April 11, 2016
Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial.
Journal: Targeted oncology
Published: April 02, 2016
Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer.
Journal: International journal of clinical oncology
Published: September 24, 2015
Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the "Hispanic paradox".
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 04, 2015
Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.
Journal: The oncologist
Published: February 12, 2015
High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with (99m)Tc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin.
Journal: Cancer chemotherapy and pharmacology
Published: March 31, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026